Found: 111
Select item for more details and to access through your institution.
M2‐polarized tumor‐associated macrophages promote epithelial‐mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma.
- Published in:
- Journal of Cellular Biochemistry, 2020, v. 121, n. 4, p. 2828, doi. 10.1002/jcb.29514
- By:
- Publication type:
- Article
The Human Male Liver Is Predisposed to Inflammation Via Enhanced Myeloid Responses to Inflammatory Triggers.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.818612
- By:
- Publication type:
- Article
Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 11, p. 1914, doi. 10.1093/cid/ciab764
- By:
- Publication type:
- Article
DNA Methylation and Immune Cell Markers Demonstrate Evidence of Accelerated Aging in Patients with Chronic Hepatitis B Virus or Hepatitis C Virus, with or without Human Immunodeficienct Virus Co-infection.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 1, p. e184, doi. 10.1093/cid/ciaa1371
- By:
- Publication type:
- Article
Evaluation of Sustained Virologic Response as a Relevant Surrogate Endpoint for Long-term Outcomes of Hepatitis C Virus Infection.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 5, p. 780, doi. 10.1093/cid/ciaa144
- By:
- Publication type:
- Article
Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 2, p. 202, doi. 10.1093/cid/ciaa013
- By:
- Publication type:
- Article
Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 113, doi. 10.1093/infdis/jiac210
- By:
- Publication type:
- Article
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis B.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 18, p. 1927, doi. 10.1001/jama.2014.12627
- By:
- Publication type:
- Article
Sustained virological response to treatment in patients with chronic hepatitis C--reply.
- Published in:
- 2013
- By:
- Publication type:
- commentary
Sustained Virological Response to Treatment in Patients With Chronic Hepatitis C.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Association Between Sustained Virological Response and AlI-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 24, p. 2584, doi. 10.1001/jama.2012.144878
- By:
- Publication type:
- Article
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 4, p. 680, doi. 10.1093/cid/cix353
- By:
- Publication type:
- Article
Close Monitoring of Hepatitis B Surface Antigen Levels Helps Classify Flares During Peginterferon Therapy and Predicts Treatment Response.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 1, p. 100, doi. 10.1093/cid/cis859
- By:
- Publication type:
- Article
Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps.
- Published in:
- Liver International, 2020, v. 40, n. 2, p. 382, doi. 10.1111/liv.14326
- By:
- Publication type:
- Article
Prevalence and predictors of complementary and alternative medicine modalities in patients with chronic hepatitis B.
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1418, doi. 10.1111/liv.14105
- By:
- Publication type:
- Article
Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and Canada.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 5, p. N.PAG, doi. 10.1093/ofid/ofz175
- By:
- Publication type:
- Article
New approaches in the management of chronic hepatitis B: role of tenofovir.
- Published in:
- Infection & Drug Resistance, 2009, v. 2, p. 13
- By:
- Publication type:
- Article
Quantitative assessment of hepatitis B virus DNA in chronic hepatitis B: comparison of two solution hybridization assays.
- Published in:
- Journal of Medical Virology, 1993, v. 40, n. 4, p. 307, doi. 10.1002/jmv.1890400408
- By:
- Publication type:
- Article
Time to make the change from 'primary biliary cirrhosis' to 'primary biliary cholangitis'.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2015, v. 29, n. 6, p. 293, doi. 10.1155/2015/764684
- By:
- Publication type:
- Article
Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians.
- Published in:
- Quality of Life Research, 2008, v. 17, n. 2, p. 195, doi. 10.1007/s11136-008-9308-7
- By:
- Publication type:
- Article
Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study).
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 4, p. 197, doi. 10.1111/jvh.13918
- By:
- Publication type:
- Article
Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 1, p. 64, doi. 10.1111/jvh.13761
- By:
- Publication type:
- Article
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 11, p. 986, doi. 10.1111/jvh.13742
- By:
- Publication type:
- Article
The impact of the first, second and third waves of covid‐19 on hepatitis B and C testing in Ontario, Canada.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 3, p. 205, doi. 10.1111/jvh.13637
- By:
- Publication type:
- Article
Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 12, p. 1729, doi. 10.1111/jvh.13613
- By:
- Publication type:
- Article
Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 11, p. 1526, doi. 10.1111/jvh.13591
- By:
- Publication type:
- Article
Clinical significance of quantitative e antigen in a cohort of hepatitis B virus‐infected children and adults in North America.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 7, p. 1042, doi. 10.1111/jvh.13520
- By:
- Publication type:
- Article
Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 1, p. 51, doi. 10.1111/jvh.13401
- By:
- Publication type:
- Article
Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg‐positive chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 6, p. 610, doi. 10.1111/jvh.13272
- By:
- Publication type:
- Article
Liver safety assessment in clinical trials of new agents for chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 2, p. 96, doi. 10.1111/jvh.13223
- By:
- Publication type:
- Article
Elevated serum levels of soluble CD14 in HBeAg‐positive chronic HBV patients upon Peginterferon treatment are associated with treatment response.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 9, p. 1076, doi. 10.1111/jvh.13127
- By:
- Publication type:
- Article
Hepatitis B core‐related antigen monitoring during peginterferon alfa treatment for HBeAg‐negative chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 10, p. 1156, doi. 10.1111/jvh.13117
- By:
- Publication type:
- Article
Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 7, p. 856, doi. 10.1111/jvh.13104
- By:
- Publication type:
- Article
Relationship between hepatitis B core‐related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 7, p. 828, doi. 10.1111/jvh.13097
- By:
- Publication type:
- Article
Sustained off‐treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced HBeAg seroconversion.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 6, p. 766, doi. 10.1111/jvh.13084
- By:
- Publication type:
- Article
Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 1, p. 109, doi. 10.1111/jvh.12997
- By:
- Publication type:
- Article
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 5, p. 509, doi. 10.1111/apt.17299
- By:
- Publication type:
- Article
Liver transplant‐free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 9, p. 1408, doi. 10.1111/apt.17226
- By:
- Publication type:
- Article
Editorial: only steps away from primetime? Hepatitis B virus RNA as a routine marker to guide HBV treatment decisions—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 7, p. 972, doi. 10.1111/apt.16570
- By:
- Publication type:
- Article
Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 709, doi. 10.1111/apt.16538
- By:
- Publication type:
- Article
Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 689, doi. 10.1111/apt.16488
- By:
- Publication type:
- Article
Editorial: HBV cure—the quest for biomarkers to predict off‐treatment sustained response. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 4, p. 555, doi. 10.1111/apt.16233
- By:
- Publication type:
- Article
Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 314, doi. 10.1111/apt.16172
- By:
- Publication type:
- Article
Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus‐infected patients with low ALT levels in the absence of significant fibrosis—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 1, p. 215, doi. 10.1111/apt.16183
- By:
- Publication type:
- Article
Editorial: identifying candidates for pegylated interferon add‐on to entecavir therapy in patients with HBeAg‐positive chronic hepatitis B – authors' reply.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 4, p. 448, doi. 10.1111/apt.15098
- By:
- Publication type:
- Article
Etiology, Management, and Outcome of the Budd-Chiari Syndrome.
- Published in:
- Annals of Internal Medicine, 2009, v. 151, n. 3, p. 167, doi. 10.7326/0003-4819-151-3-200908040-00004
- By:
- Publication type:
- Article
Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis.
- Published in:
- Annals of Internal Medicine, 2007, v. 147, n. 10, p. 677, doi. 10.7326/0003-4819-147-10-200711200-00003
- By:
- Publication type:
- Article